2015
DOI: 10.1016/j.main.2015.08.005
|View full text |Cite
|
Sign up to set email alerts
|

Arthroscopic interposition in thumb carpometacarpal osteoarthritis: A series of 26 cases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
18
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 14 publications
(21 citation statements)
references
References 22 publications
0
18
0
Order By: Relevance
“…20 Arthroscopy can be supplemented by interposition of different biological or manufactured materials. [4][5][6]17 Poly-L-lactic acid (PLLA) implant is a common synthetic interposition material. Pereira et al 3 provided controversial results by combining PLLA with arthroscopy in their long-term follow-up study.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…20 Arthroscopy can be supplemented by interposition of different biological or manufactured materials. [4][5][6]17 Poly-L-lactic acid (PLLA) implant is a common synthetic interposition material. Pereira et al 3 provided controversial results by combining PLLA with arthroscopy in their long-term follow-up study.…”
Section: Discussionmentioning
confidence: 99%
“…4 Synthetic interposition material has the disadvantage of high costs and possible inflammatory or allergic reactions. 5,6 Herold et al first published autologous fat grafts in the thumb CMC joint. In this study, five patients were treated successfully only by fat graft, which was instilled under X-ray control.…”
mentioning
confidence: 99%
“…Of other bioabsorbable interposition implants used in TMC arthroplasty, the Artelon™ spacer (Artimplant, Västra Frölunda, Sweden) consisting of partially degradable polyurethane urea has been documented to cause similar adverse tissue reactions as in our patients at 1 year post-operatively (Richard et al., 2014). The Arex™ implant (Arex, Paris, France) consisting of very slowly degrading pure poly-L-lactide (without a D-isomeric form as in the PLDLA (96/4) implant) has also been associated with adverse tissue reactions (Diaconu et al., 2011; Pereira et al., 2015; Semere et al., 2013). Some of these have occurred at the surprisingly early stage of 3 weeks post-operatively (Diaconu et al., 2011) and with implant removal being done as early as 4 months post-operatively (Semere et al., 2013).…”
Section: Discussionmentioning
confidence: 99%
“…Complete removal of the trapezium probably decreases the mechanical stress on the implant thus decreasing the magnitude of the foreign-body reaction. Regarding biocompatibility, the results of the RegJoint™ implant seem better than those of the similar bioabsorbable Arex implant (Arex, Palaiseau, France) and several nonabsorbable implants that have caused adverse tissue reactions in several studies (Pereira et al., 2015; Semere et al., 2013; Spaans et al., 2014; Willekens et al., 2016).…”
Section: Discussionmentioning
confidence: 95%